| # | Drug | Count |
|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 4175 |
| 1 | DULAGLUTIDE | 2003 |
| 2 | METFORMIN | 1895 |
| 3 | TIRZEPATIDE | 1873 |
| 4 | METFORMIN ER 500 MG | 1801 |
| 5 | METFORMIN ER 750 MG | 1801 |
| 6 | OMEPRAZOLE MAGNESIUM | 1019 |
| 7 | GABAPENTIN | 1003 |
| 8 | INSULIN GLARGINE | 963 |
| 9 | OMEPRAZOLE | 840 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ORAL SEMAGLUTIDE | 4175 | 0.0535 |
| 1 | DULAGLUTIDE | 2003 | 0.0224 |
| 2 | PRUCALOPRIDE | 48 | 0.0203 |
| 3 | ERGOCALCIFEROL | 585 | 0.0197 |
| 4 | GOLD | 106 | 0.0183 |
| 5 | PLECANATIDE | 32 | 0.0154 |
| 6 | INSULIN DEGLUDEC | 362 | 0.0151 |
| 7 | PHENTERMINE HYDROCHLORIDE | 92 | 0.0141 |
| 8 | PSYLLIUM HUSK | 19 | 0.0141 |
| 9 | DICYCLOMINE HYDROCHLORIDE | 198 | 0.0136 |
| # | Drug class | Count |
|---|---|---|
| 0 | GLP-1 Receptor Agonist [EPC] | 6390 |
| 1 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 1873 |
| 2 | Insulin Analog [EPC] | 1752 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1564 |
| 4 | Proton Pump Inhibitor [EPC] | 1191 |
| 5 | Benzodiazepine [EPC] | 1132 |
| 6 | Corticosteroid [EPC] | 897 |
| 7 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 765 |
| 8 | HMG-CoA Reductase Inhibitor [EPC] | 764 |
| 9 | Sulfonylurea [EPC] | 682 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 215 | 0.1036 |
| 1 | Serotonin-4 Receptor Agonist [EPC] | 16 | 0.0243 |
| 2 | Interleukin-5 Antagonist [EPC] | 14 | 0.0203 |
| 3 | Provitamin D2 Compound [EPC] | 585 | 0.0197 |
| 4 | GLP-1 Receptor Agonist [EPC] | 6390 | 0.0143 |
| 5 | Polymyxin-class Antibacterial [EPC] | 1 | 0.0137 |
| 6 | Farnesyltransferase Inhibitor [EPC] | 1 | 0.0128 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 69 | 0.0099 |
| 8 | APOC-III-directed RNA Interaction [EPC] | 1 | 0.0096 |
| 9 | Aluminum Complex [EPC] | 228 | 0.0094 |